Abraxane is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Abraxane is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameAbraxane
Authorized genericpaclitaxel
Regular genericpaclitaxel
What you’d pay
Cash priceAsk the pharmacyUsually the highest price
Not soldThere isn’t one
Cash priceAsk the pharmacyUsually the lowest
Same as Abraxane?
The original
–
Same active ingredientFillers and dyes can differ

Brand nameThe maker’s card

BMS Access Support Co-Pay Assistance Program

Savings card from Bristol Myers Squibb

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 an infusion

Sign up on bmsaccesssupport.com 

Or call 1-800-861-0048.

In the maker’s words

“Eligible patients may pay as little as $0 per infusion, subject to a maximum benefit.”

From the maker’s offer on bmsaccesssupport.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Abraxane itself, from the same company, sold without the brand name, and usually for less. A regular generic is sold, with the same active ingredient: ask the pharmacy for its price.

See the regular generic →

Regular genericWho makes it

7 companies sell an FDA-rated generic of Abraxane. It’s given by your care team, who choose which one to use.

  • BluePoint Laboratories100 mg/20 mL

    Sold as Paclitaxel protein-bound particles for injectable suspension (albumin-bound) · Made by Hainan Shuangcheng Pharmaceuticals

    How it looks, what’s in it, NDCs

    100 mg/20 mL

    PackageNDC
    Carton of 20 mL68001-651-37

    Inactive ingredients: albumin human

    FDA label

  • Cipla100 mg/20 mL
    How it looks, what’s in it, NDCs

    100 mg/20 mL

    PackageNDC
    Carton of 20 mL69097-398-78

    Inactive ingredients: albumin human

    FDA label

  • Exelan Pharmaceuticals100 mg/20 mL

    Sold as Paclitaxel 100mg per vial · Made by Cipla

    How it looks, what’s in it, NDCs

    100 mg/20 mL

    PackageNDC
    Carton of 20 mL76282-768-09

    Inactive ingredients: albumin human

    FDA label

  • Meitheal Pharmaceuticals100 mg/20 mL

    Sold as Paclitaxel protein-bound particles for injectable suspension (albumin-bound) · Made by Hainan Shuangcheng Pharmaceuticals

    Product page on meithealpharma.com

    How it looks, what’s in it, NDCs

    100 mg/20 mL

    PackageNDC
    Carton of 20 mL71288-183-50

    Inactive ingredients: albumin human

    FDA label

  • Mylan Institutional100 mg/20 mL
    How it looks, what’s in it, NDCs

    100 mg/20 mL

    PackageNDC
    Vial of 20 mL67457-937-50

    Inactive ingredients: albumin human

    FDA label

  • NorthStar Rx100 mg/20 mL

    Sold as Paclitaxel protein-bound particles for injectable suspension (albumin-bound) · Made by Hainan Shuangcheng Pharmaceuticals

    Product page on northstarrxllc.com

    How it looks, what’s in it, NDCs

    100 mg/20 mL

    PackageNDC
    Carton of 20 mL72603-408-01

    Inactive ingredients: albumin human

    FDA label

  • Sandoz100 mg/20 mL

    Made by Jiangsu Hengrui Pharmaceuticals

    Product page on sandoz.com

    How it looks, what’s in it, NDCs

    100 mg/20 mL

    PackageNDC
    Carton of 20 mL0781-3531-91

    Inactive ingredients: albumin human

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What it’s used for

What the FDA label says

ABRAXANE is a microtubule inhibitor indicated for the treatment of:

  • Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.
  • Locally advanced or metastatic non-small cell lung cancer (NSCLC), as first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.
  • Metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine.

Source: the FDA label for Abraxane (Abraxis BioScience, LLC), October 31, 2022. Full label on DailyMed 

Good to know